4th Circ. Revives Purdue Pharma OxyContin FCA Row

Law360, New York (December 12, 2013, 3:04 PM EST) -- The Fourth Circuit on Thursday revived a qui tam lawsuit accusing Purdue Pharma LP of violating the False Claims Act by falsely marketing painkiller OxyContin, vacating a lower court’s ruling that had tossed the case for being virtually identical to a previous one that was dismissed after being brought by the relator’s husband.

A three-judge panel found that the res judicata doctrine — which bars the filing of new cases that are nearly identical to cases that have already been litigated to conclusion — does not...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

US ex rel. Steven May v. Purdue Pharma L.P.


Case Number

12-2287

Court

Appellate - 4th Circuit

Nature of Suit

2890 Other Statutory Actions

Date Filed

October 18, 2012

Law Firms

Companies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.